Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Gene-specific contributions to mumps virus neurovirulence and neuroattenuation.

Sauder CJ, Zhang CX, Ngo L, Werner K, Lemon K, Duprex WP, Malik T, Carbone K, Rubin SA.

J Virol. 2011 Jul;85(14):7059-69. doi: 10.1128/JVI.00245-11. Epub 2011 May 4.

2.

Attenuation of virulence with retention of antigenicity of mumps virus after passage in the embryonated egg.

ENDERS JF, LEVENS JH, et al.

J Immunol. 1946 Nov;54(3):283-91. No abstract available.

PMID:
21001446
3.

Mumps outbreak in the Republic of Moldova, 2007-2008.

Schwarz NG, Bernard H, Melnic A, Bucov V, Caterinciuc N, an der Heiden M, Andrews N, Pebody R, Aidyralieva C, Hahné S.

Pediatr Infect Dis J. 2010 Aug;29(8):703-6. doi: 10.1097/INF.0b013e3181d743df.

PMID:
20308934
4.

[Comparison of genotype characteristics between the circulating mumps virus strain in Beijing area and the vaccine strain].

Chen M, Zhang TG, Chen LJ, Wu J, Yang J, Zhang W.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Nov;30(11):1184-8. Chinese.

PMID:
20193592
5.

Update: mumps outbreak - New York and New Jersey, June 2009-January 2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Feb 12;59(5):125-9. Erratum in: MMWR Morb Mortal Wkly Rep. 2010 May 21;59(19):594. Dosage error in article text..

6.

Genotyping of mumps virus circulating in Turkey in the 2006-2007 winter season.

Akcali A, Yilmaz N, Uyar Y, Ertek M, Buzgan T.

Arch Virol. 2009;154(11):1807-12. doi: 10.1007/s00705-009-0519-1. Epub 2009 Oct 15.

PMID:
19830379
7.

Mumps resurgences in the United States: A historical perspective on unexpected elements.

Barskey AE, Glasser JW, LeBaron CW.

Vaccine. 2009 Oct 19;27(44):6186-95. doi: 10.1016/j.vaccine.2009.06.109. Review.

PMID:
19815120
8.

A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia.

Bangor-Jones RD, Dowse GK, Giele CM, van Buynder PG, Hodge MM, Whitty MM.

Med J Aust. 2009 Oct 5;191(7):398-401.

PMID:
19807634
9.

Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006.

Rota JS, Turner JC, Yost-Daljev MK, Freeman M, Toney DM, Meisel E, Williams N, Sowers SB, Lowe L, Rota PA, Nicolai LA, Peake L, Bellini WJ.

J Med Virol. 2009 Oct;81(10):1819-25. doi: 10.1002/jmv.21557.

PMID:
19697404
10.

Effectiveness of Jeryl Lynn-containing vaccine in Spanish children.

Castilla J, García Cenoz M, Arriazu M, Fernández-Alonso M, Martínez-Artola V, Etxeberria J, Irisarri F, Barricarte A.

Vaccine. 2009 Mar 26;27(15):2089-93. doi: 10.1016/j.vaccine.2009.02.001. Epub 2009 Feb 12.

PMID:
19356610
11.

Mumps outbreak on the island of Anglesey, North Wales, December 2008-January 2009.

Roberts C, Porter-Jones G, Crocker J, Hart J.

Euro Surveill. 2009 Feb 5;14(5). pii: 19109.

12.

Characterization of large mumps outbreak among vaccinated Palestinian refugees.

Hindiyeh MY, Aboudy Y, Wohoush M, Shulman LM, Ram D, Levin T, Frank T, Riccardo F, Khalili M, Sawalha ES, Obeidi M, Sabatinelli G, Grossman Z, Mendelson E.

J Clin Microbiol. 2009 Mar;47(3):560-5. doi: 10.1128/JCM.01756-08. Epub 2009 Jan 14.

13.

Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine.

LeBaron CW, Forghani B, Beck C, Brown C, Bi D, Cossen C, Sullivan BJ.

J Infect Dis. 2009 Feb 15;199(4):552-60. doi: 10.1086/596207.

PMID:
19113988
14.

Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?

Dayan GH, Rubin S.

Clin Infect Dis. 2008 Dec 1;47(11):1458-67. doi: 10.1086/591196.

PMID:
18959494
15.

An increase in the number of mumps cases in the Czech Republic, 2005-2006.

Boxall N, Kubinyiova M, Príkazský V, Benes C, Cástková J.

Euro Surveill. 2008 Apr 17;13(16). pii: 18842.

16.

Matched case-control study of effectiveness of live, attenuated S79 mumps virus vaccine against clinical mumps.

Fu C, Liang J, Wang M.

Clin Vaccine Immunol. 2008 Sep;15(9):1425-8. doi: 10.1128/CVI.00122-08. Epub 2008 Jul 30.

17.

Immunogenicity and safety of a novel formalin-inactivated and alum-adjuvanted candidate subunit vaccine for mumps.

Liang Y, Ma S, Yang Z, Liu L, Wang L, Wang J, Jiang L, Shi C, Dong C, Li Q.

Vaccine. 2008 Aug 5;26(33):4276-83. doi: 10.1016/j.vaccine.2008.05.060. Epub 2008 Jun 11.

PMID:
18597904
18.

Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.

Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, Sirota L, Beeler J.

J Infect Dis. 2008 Aug 15;198(4):508-15. doi: 10.1086/590115.

PMID:
18558869
19.

Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006.

Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW.

Vaccine. 2008 Jul 4;26(29-30):3601-7. doi: 10.1016/j.vaccine.2008.04.075. Epub 2008 May 19.

PMID:
18539365
20.

Mumps vaccine performance among university students during a mumps outbreak.

Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, Dayan GH.

Clin Infect Dis. 2008 Apr 15;46(8):1172-80. doi: 10.1086/529141.

PMID:
18444852

Supplemental Content

Support Center